By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:



Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.

Company News
VolitionRX To Host A Conference Call Regarding A 13,500 Subject Colorectal Cancer Screening Trial With The Early Detection Research Network Of The U.S. NCI 7/20/2017 6:56:38 AM
Volition America Announces A Colorectal Cancer Screening Trial Containing Approximately 13,500 Subjects In Collaboration With The Early Detection Research Network Of The U.S. NCI 7/18/2017 7:59:39 AM
Cancer Prevention Pharma In Collaboration With The NCI And Vanderbilt University Medical Center Initiates Phase II Trial To Evaluate CPP-1X In Patients With High Risk Of Gastric Cancer 7/17/2017 6:47:37 AM
Masonic Cancer Center, University of Minnesota Awarded NCI CURE Grant To Mentor Future Cancer Researchers 7/5/2017 11:08:15 AM
Caris Life Sciences, NCI And ECOG-ACRIN Collaborate To Molecularly Identify Candidates For The NCI-MATCH Clinical Trial 6/7/2017 10:04:53 AM
Foundation Medicine, Inc. (FMI) To Identify Patients Eligible For NCI’s NCI-Match (Molecular Analysis For Therapy Choice) Study 6/7/2017 8:36:58 AM
Eleven Bio (EBIO) To Collaborate With AstraZeneca PLC (AZN) And NCI On Development Of Viciniumtm In Combination With Durvalumab For The Treatment Of Non-Muscle Invasive Bladder Cancer 6/6/2017 6:48:54 AM
PLx Pharma Inc. Receives NCI Grant For Research Of Novel Aspirin Formulation To Prevent Colorectal Cancer 5/10/2017 10:20:35 AM
Selecta (SELB) Obtains License For Recombinant Immunotoxin LMB-100 From NCI) For Pancreatic Cancer, Mesothelioma And Other Cancers 5/2/2017 10:13:18 AM
IriSys, Inc. Contract With NCI For Manufacturing Clinical Trial Materials Is Doubled In Value 4/20/2017 8:03:47 AM